{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:39:58Z","timestamp":1776699598904,"version":"3.51.2"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Wesley Medical Research Foundation","award":["2020CR25"],"award-info":[{"award-number":["2020CR25"]}]},{"DOI":"10.13039\/501100018853","name":"Prince Charles Hospital Foundation","doi-asserted-by":"publisher","award":["INN2018-101"],"award-info":[{"award-number":["INN2018-101"]}],"id":[{"id":"10.13039\/501100018853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Whilst the presence of 2 subphenotypes among the heterogenous Acute Respiratory Distress Syndrome (ARDS) population is becoming clinically accepted, subphenotype-specific treatment efficacy has yet to be prospectively tested. We investigated anti-inflammatory treatment in different ARDS models in sheep, previously shown similarities to human ARDS subphenotypes, in a preclinical, randomized, blinded study. Thirty anesthetized sheep were studied up to 48\u00a0h and randomized into: (a) OA: oleic acid (n\u2009=\u200915) and (b) OA-LPS: oleic acid and subsequent lipopolysaccharide (n\u2009=\u200915) to achieve a PaO<jats:sub>2<\/jats:sub>\/FiO<jats:sub>2<\/jats:sub> ratio of\u2009&lt;\u2009150\u00a0mmHg. Then, animals were randomly allocated to receive treatment with methylprednisolone or erythromycin or none. Assessed outcomes were oxygenation, pulmonary mechanics, hemodynamics and survival. All animals reached ARDS. Treatment with methylprednisolone, but not erythromycin, provided the highest therapeutic benefit in Ph2 animals, leading to a significant increase in PaO<jats:sub>2<\/jats:sub>\/FiO<jats:sub>2<\/jats:sub> ratio by reducing pulmonary edema, dead space ventilation and shunt fraction. Animals treated with methylprednisolone displayed a higher survival up to 48\u00a0h than all others. In animals treated with erythromycin, there was no treatment benefit regarding assessed physiological parameters and survival in both phenotypes. Treatment with methylprednisolone improves oxygenation and survival, more so in ovine phenotype 2 which resembles the human hyperinflammatory subphenotype.<\/jats:p>","DOI":"10.1038\/s41598-023-45081-8","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T21:01:39Z","timestamp":1697835699000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Application of anti-inflammatory treatment in two different ovine Acute Respiratory Distress Syndrome injury models: a preclinical randomized intervention study"],"prefix":"10.1038","volume":"13","author":[{"given":"Karin","family":"Wildi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Livingstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Ainola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiano Maria","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silver","family":"Heinsar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mah\u00e9","family":"Bouquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Passmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieran","family":"Hyslop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keibun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise E.","family":"See Hoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Seung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Laffey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Pelosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluigi","family":"Li Bassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacky","family":"Suen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"45081_CR1","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(67)90168-7","volume":"2","author":"DG Ashbaugh","year":"1967","unstructured":"Ashbaugh, D. G., Bigelow, D. B., Petty, T. L. & Levine, B. E. Acute respiratory distress in adults. Lancet 2, 319\u2013323 (1967).","journal-title":"Lancet"},{"key":"45081_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","volume":"342","author":"RG Brower","year":"2000","unstructured":"Brower, R. G. et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N. Engl. J. Med. 342, 1301\u20131308 (2000).","journal-title":"N. Engl. J. Med."},{"key":"45081_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa032193","volume":"351","author":"RG Brower","year":"2004","unstructured":"Brower, R. G. et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N. Engl. J. Med. 351, 327\u2013336 (2004).","journal-title":"N. Engl. J. Med."},{"key":"45081_CR4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","volume":"315","author":"G Bellani","year":"2016","unstructured":"Bellani, G. et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. J. Am. Med. Assoc. 315, 788\u2013800 (2016).","journal-title":"J. Am. Med. Assoc."},{"key":"45081_CR5","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJMoa1011802","volume":"364","author":"MS Herridge","year":"2011","unstructured":"Herridge, M. S. et al. Functional disability 5 years after acute respiratory distress syndrome. N. Eng. J. Med. 364, 1293\u20131304 (2011).","journal-title":"N. Eng. J. Med."},{"key":"45081_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06289-8","author":"GU Meduri","year":"2020","unstructured":"Meduri, G. U. et al. Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS. Int. Care Med. https:\/\/doi.org\/10.1007\/s00134-020-06289-8 (2020).","journal-title":"Int. Care Med."},{"key":"45081_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","volume":"8","author":"J Villar","year":"2020","unstructured":"Villar, J. et al. Dexamethasone treatment for the acute respiratory distress syndrome: A multicentre, randomised controlled trial. Lancet Respir. Med. 8, 267\u2013276 (2020).","journal-title":"Lancet Respir. Med."},{"key":"45081_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40560-018-0321-9","volume":"6","author":"GU Meduri","year":"2018","unstructured":"Meduri, G. U., Siemieniuk, R. A. C., Ness, R. A. & Seyler, S. J. Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS. J. Intensive Care 6, 1\u20137 (2018).","journal-title":"J. Intensive Care"},{"key":"45081_CR9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","volume":"2","author":"CS Calfee","year":"2014","unstructured":"Calfee, C. S. et al. Latent class analysis of ARDS subphenotypes: Analysis of data from two randomized controlled trials. Lancet Respir. Med. 2, 611\u2013620 (2014).","journal-title":"Lancet Respir. Med."},{"key":"45081_CR10","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1136\/thoraxjnl-2016-209719","volume":"72","author":"LD Bos","year":"2017","unstructured":"Bos, L. D. et al. Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis. Thorax 72, 876\u2013883 (2017).","journal-title":"Thorax"},{"key":"45081_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1164\/rccm.201603-0645OC","volume":"195","author":"KR Famous","year":"2017","unstructured":"Famous, K. R. et al. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am. J. Respir. Crit. Care Med. 195, 331\u2013338 (2017).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"45081_CR12","first-page":"1","volume":"0","author":"CS Calfee","year":"2018","unstructured":"Calfee, C. S. et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: Secondary analysis of a randomised controlled trial. Lancet Respir. Med. 0, 1\u20138 (2018).","journal-title":"Lancet Respir. Med."},{"key":"45081_CR13","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s00134-018-5378-3","volume":"44","author":"P Sinha","year":"2018","unstructured":"Sinha, P. et al. Latent class analysis of ARDS subphenotypes: A secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study. Int. Care Med. 44, 1859\u20131869 (2018).","journal-title":"Int. Care Med."},{"key":"45081_CR14","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1164\/rccm.202105-1302OC","volume":"204","author":"P Sinha","year":"2021","unstructured":"Sinha, P. et al. Latent class analysis reveals COVID-19-related acute respiratory distress syndrome subgroups with differential responses to corticosteroids. Am. J. Respir. Crit. Care Med. 204, 1274\u20131285 (2021).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"45081_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144345","volume":"10","author":"P Enkhbaatar","year":"2015","unstructured":"Enkhbaatar, P. et al. Comparison of gene expression by sheep and human blood stimulated with the TLR4 agonists lipopolysaccharide and monophosphoryl lipid A. PLoS ONE 10, e0144345 (2015).","journal-title":"PLoS ONE"},{"key":"45081_CR16","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15048","author":"JE Millar","year":"2021","unstructured":"Millar, J. E. et al. Characterizing preclinical sub-phenotypic models of acute respiratory distress syndrome: An experimental ovine study. Physiol. Rep. https:\/\/doi.org\/10.14814\/phy2.15048 (2021).","journal-title":"Physiol. Rep."},{"key":"45081_CR17","doi-asserted-by":"publisher","DOI":"10.1101\/2022.03.31.22272425","author":"A Sarma","year":"2022","unstructured":"Sarma, A. et al. Hyperinflammatory ARDS is characterized by interferon-stimulated gene expression, T-cell activation, and an altered metatranscriptome in tracheal aspirates. Prepr. medRxiv https:\/\/doi.org\/10.1101\/2022.03.31.22272425 (2022).","journal-title":"Prepr. medRxiv"},{"key":"45081_CR18","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1165\/rcmb.2009-0210ST","volume":"44","author":"G Matute-Bello","year":"2011","unstructured":"Matute-Bello, G. et al. An official American Thoracic Society Workshop Report: Features and measurements of experimental acute lung injury in animals. Am. J. Resp. Cell. Mol. Biol. 44, 725\u2013738 (2011).","journal-title":"Am. J. Resp. Cell. Mol. Biol."},{"key":"45081_CR19","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1165\/rcmb.2021-0531ST","volume":"66","author":"HS Kulkarni","year":"2022","unstructured":"Kulkarni, H. S. et al. Update on the features and measurements of experimental acute lung injury in animals: An official American Thoracic Society workshop report. Am. J. Respir. Cell Mol. Biol. 66, e1\u2013e14 (2022).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"45081_CR20","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1378\/chest.130.2.392","volume":"130","author":"T Luecke","year":"2006","unstructured":"Luecke, T. et al. Oleic acid vs saline solution lung lavage-induced acute lung injury. Chest 130, 392\u2013401 (2006).","journal-title":"Chest"},{"key":"45081_CR21","doi-asserted-by":"publisher","first-page":"112835","DOI":"10.1016\/j.jim.2020.112835","volume":"486","author":"M Bouquet","year":"2020","unstructured":"Bouquet, M. et al. Development and validation of ELISAs for the quantitation of interleukin (IL)-1\u03b2, IL-6, IL-8 and IL-10 in ovine plasma. J. Immunol. Methods 486, 112835 (2020).","journal-title":"J. Immunol. Methods"},{"key":"45081_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/thoraxjnl-2013-204980","volume":"69","author":"S Asmussen","year":"2014","unstructured":"Asmussen, S. et al. Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia. Thorax 69, 819\u2013825 (2014).","journal-title":"Thorax"},{"key":"45081_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0112653","volume":"9","author":"M Casals","year":"2014","unstructured":"Casals, M., Girabent-Farr\u00e9s, M. & Carrasco, J. L. Methodological quality and reporting of generalized linear mixed models in clinical medicine (2000\u20132012): A systematic review. PLoS ONE 9, 1\u201310 (2014).","journal-title":"PLoS ONE"},{"key":"45081_CR24","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1001\/jama.2018.17977","volume":"320","author":"AE McGlothlin","year":"2018","unstructured":"McGlothlin, A. E. & Viele, K. Bayesian hierarchical models. J. Am. Med. Assoc. 320, 2365\u20132366 (2018).","journal-title":"J. Am. Med. Assoc."},{"key":"45081_CR25","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1164\/ajrccm\/144.3_Pt_1.586","volume":"144","author":"LS Greos","year":"1991","unstructured":"Greos, L. S. et al. Methylprednisolone achieves greater concentrations in the lung than prednisolone: A pharmacokinetic analysis. Am. Rev. Respir. Dis. 144, 586\u2013592 (1991).","journal-title":"Am. Rev. Respir. Dis."},{"key":"45081_CR26","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"T Rhen","year":"2005","unstructured":"Rhen, T. & Cidlowski, J. A. Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs. N. Engl. J. Med. 353, 1711\u20131723 (2005).","journal-title":"N. Engl. J. Med."},{"key":"45081_CR27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000091126","volume":"12","author":"GU Meduri","year":"2005","unstructured":"Meduri, G. U., Muthiah, M. P., Carrat\u00f9, P., Eltorky, M. & Chrousos, G. P. Nuclear factor-\u0138B- and glucocorticoid receptor \u03b1-mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Neuroimmunomodulation 12, 321\u2013338 (2005).","journal-title":"Neuroimmunomodulation"},{"key":"45081_CR28","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1164\/ajrccm.165.7.2106014","volume":"165","author":"G Umberto Meduri","year":"2002","unstructured":"Umberto Meduri, G., Tolley, E. A., Chrousos, G. P. & Stentz, F. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: Evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am. J. Respir. Crit. Care Med. 165, 983\u2013991 (2002).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"45081_CR29","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1164\/ajrccm.160.4.9901075","volume":"160","author":"MA Jantz","year":"1999","unstructured":"Jantz, M. A. & Sahn, S. A. Corticosteroids in acute respiratory failure. Am. J. Respir. Crit. Care Med. 160, 1079\u20131100 (1999).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"45081_CR30","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1586\/ers.10.71","volume":"4","author":"H Chen","year":"2010","unstructured":"Chen, H., Bai, C. & Wang, X. The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Rev. Respir. Med. 4, 773\u2013783 (2010).","journal-title":"Expert Rev. Respir. Med."},{"key":"45081_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/00024382-200013020-00001","volume":"13","author":"P Moine","year":"2000","unstructured":"Moine, P. et al. NF-\u03baB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. Shock 13, 85\u201391 (2000).","journal-title":"Shock"},{"key":"45081_CR32","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1164\/rccm.200205-446OC","volume":"167","author":"D Keh","year":"2003","unstructured":"Keh, D. et al. Immunologic and hemodynamic effects of \u2018low-dose\u2019 hydrocortisone in septic shock: A double-blind, randomized, placebo-controlled, crossover study. Am. J. Respir. Crit. Care Med. 167, 512\u2013520 (2003).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"45081_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/01.CCM.0000194723.78632.62","volume":"34","author":"D Annane","year":"2006","unstructured":"Annane, D., S\u00e9bille, V. & Bellissant, E. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit. Care Med. 34, 22\u201330 (2006).","journal-title":"Crit. Care Med."},{"key":"45081_CR34","first-page":"2066","volume":"83","author":"ZA Erkut","year":"1998","unstructured":"Erkut, Z. A., Pool, C. & Swaab, D. F. Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons 1. J. Clin. Endocrinol. Metab. 83, 2066\u20132073 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"45081_CR35","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/S0954-6111(03)00042-8","volume":"97","author":"J Kadota","year":"2003","unstructured":"Kadota, J. et al. Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis. Respir. Med. 97, 844\u2013850 (2003).","journal-title":"Respir. Med."},{"key":"45081_CR36","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S0140-6736(02)11081-6","volume":"360","author":"A Equi","year":"2002","unstructured":"Equi, A., Balfour-Lynn, I. M., Bush, A. & Rosenthal, M. Long term azithromycin in children with cystic fibrosis: A randomised, placebo-controlled crossover trial. Lancet 360, 978\u2013984 (2002).","journal-title":"Lancet"},{"key":"45081_CR37","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1378\/chest.11-1908","volume":"141","author":"AJ Walkey","year":"2012","unstructured":"Walkey, A. J. & Wiener, R. S. Macrolide antibiotics and survival in patients with acute lung injury. Chest 141, 1153\u20131159 (2012).","journal-title":"Chest"},{"key":"45081_CR38","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1164\/ajrccm.151.5.7735618","volume":"151","author":"J Tamaoki","year":"1995","unstructured":"Tamaoki, J. et al. Effect of erythromycin on endotoxin-induced microvascular leakage in the rat trachea and lungs. Am. J. Respir. Crit. Care Med. 151, 1582\u20131588 (1995).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"45081_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21037\/atm.2017.12.25","volume":"6","author":"FD Simonis","year":"2018","unstructured":"Simonis, F. D. et al. Macrolide therapy is associated with reduced mortality in acute respiratory distress syndrome (ARDS) patients. Ann. Transl. Med. 6, 24\u201331 (2018).","journal-title":"Ann. Transl. Med."},{"key":"45081_CR40","first-page":"5","volume":"117","author":"J Tamaoki","year":"2004","unstructured":"Tamaoki, J., Kadota, J. & Takizawa, H. Clinical implications of the immunomodulatory effects of macrolides. Am. J. Med. Suppl. 117, 5\u201311 (2004).","journal-title":"Am. J. Med. Suppl."},{"key":"45081_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-022-06871-2","author":"A Conway Morris","year":"2022","unstructured":"Conway Morris, A., Rynne, J. & Shankar-Hari, M. Compartmentalisation of immune responses in critical illness: Does it matter?. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-022-06871-2 (2022).","journal-title":"Intensive Care Med."},{"key":"45081_CR42","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S2213-2600(20)30124-7","volume":"8","author":"K Reddy","year":"2020","unstructured":"Reddy, K. et al. Subphenotypes in critical care: Translation into clinical practice. Lancet Resp. Med. 8, 631\u2013643 (2020).","journal-title":"Lancet Resp. Med."},{"issue":"2","key":"45081_CR43","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.1097\/SLA.0000000000003974","volume":"275","author":"LPA Neyton","year":"2020","unstructured":"Neyton, L. P. A. et al. Molecular patterns in acute pancreatitis reflect generalizable endotypes of the host response to systemic injury in humans. Ann. Surg. 275(2), e453\u2013e462 (2020).","journal-title":"Ann. Surg."},{"key":"45081_CR44","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1152\/jappl.1990.69.3.956","volume":"69","author":"K Tsuno","year":"1990","unstructured":"Tsuno, K., Prato, P. & Kolobow, T. Acute lung injury from mechanical ventilation at moderately high airway pressures. J. Appl. Physiol. 69, 956\u2013961 (1990).","journal-title":"J. Appl. Physiol."},{"key":"45081_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-022-00435-w","author":"LDJ Bos","year":"2022","unstructured":"Bos, L. D. J. et al. Towards a biological definition of ARDS: Are treatable traits the solution?. Intensive Care Med. Exp. https:\/\/doi.org\/10.1186\/s40635-022-00435-w (2022).","journal-title":"Intensive Care Med. Exp."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45081-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45081-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45081-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T07:05:00Z","timestamp":1700291100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45081-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["45081"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-45081-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,20]]},"assertion":[{"value":"20 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was funded by the Wesley Medical Research Foundation (2020CR25) and an innovation grant by the Prince Charles Hospital Foundation (INN2018-101) (all KW). The funders had no role in the design of the study, data collection, analysis and interpretation as well as in writing the manuscript.Dr. Karin Wildi has received research funding from the Gottfried and Julia Bangerter-Rhyner Foundation, the University of Basel, the Wesley Medical Research Foundation and the Prince Charles Hospital Foundation. In addition, she received a PhD scholarship from the University of Queensland (UQ). Samantha Livingstone received a PhD scholarship from the Prince Charles Hospital Foundation. Keibun Liu received a research grant from Senko Medical Instrument Mfg. Co., Ltd and the Prince Charles Hospital Foundation. Silver Heinsar and Kei Sato received a PhD scholarship from the University of Queensland. Christian Mueller received research support from the Swiss National Science Foundation, the Swiss Heart Foundation, the KTI, the University Hospital Basel, the University of Basel, Abbott, Beckman Coulter, Idorsia, Novartis, Ortho Clinical Diagnostics, Quidel, Roche, Siemens, as well as speaker honoraria\/consulting honoraria from Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, BMS, Daiichi Sankyo, Idorsia, Novartis, Osler, Roche, and Sanofi, outside the submitted work. Jacky Suen received an Advance Queensland Industry Research Fellowship. Gianluigi Li\u00a0Bassi acknowledges receipt of a \u201cBITRECS\u201d fellowship; the \u201cBITRECS\u201d project has received funding from the European Union\u2019s Horizon 2020 research and innovation program under the Marie Sk\u0142odowska-Curie grant agreement no. 754550 and from the \u201cLa Caixa\u201d Foundation (ID 100010434), under the agreement LCF\/PR\/GN18\/50310006. Gianluigi Li\u00a0Bassi also received research grants from Fisher& Paykel through his affiliated research institution. All other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17986"}}